Hoth Therapeutics Inc. Announces the Addition of Dr. Adam Friedman, M.D. to the Company's Scientific Advisory Board
February 25, 2019 08:00 ET
|
Hoth Therapeutics, Inc
NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Hoth Therapeutics, Inc.(NASDAQ:HOTH), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from...